According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...

The US Diabetes Drug Therapy Market holds a significant position globally, supported by a high prevalence of diabetes, strong healthcare spending, and widespread adoption of advanced treatment options. The increasing use of innovative drug classes, including GLP-1 receptor agonists, SGLT2 inhibitors, and next-generation insulin therapies, is driving market growth across the country. Favorable...